SCHEMBL11895062

SCHEMBL11895062

COc1ccc(C2=C3C=CC(=N3)C(c3ccc(F)c(C)c3)=C3C=CC(=N3)C(c3ccc(OC)cc3)=C3C=CC(=N3)C(c3ccc(F)c(C)c3)=C3C=CC2=N3)cc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 1/20 0.40
▸ RPS6KA3 P51812 1/20 0.36
▸ DYRK1A Q13627 1/20 0.35
▸ NFE2L2 Q16236 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ CYP11B1 P15538 1/20 0.34
▸ CYP11B2 P19099 1/20 0.34
▸ ME2 P23368 1/20 0.33
▸ ME1 P48163 1/20 0.33
▸ ME3 Q16798 1/20 0.33
▸ NT5E P21589 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ PTGS1 P23219 2/20 0.33
▸ APP P05067 1/20 0.33
▸ TP53 P04637 1/20 0.32
▸ TLR8 Q9NR97 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1680192 0.85 ME2 (0.43) DYRK1ANPC1RAB9AME2ME1
Hydrochloric Acid SCHEMBL5534014 0.83 ME2 (0.42) DYRK1ANPC1RAB9AME2ME1
Hydrochloric Acid SCHEMBL15769036 0.82 ME2 (0.41) DYRK1ANPC1RAB9AME2ME1
SCHEMBL4410281 0.78 ESR2 (0.56) NPC1RAB9AME2ME1ME3
SCHEMBL11692690 0.77 DYRK1A (0.50) TNFDYRK1ANPC1RAB9ACYP11B1
SCHEMBL433808 0.73 DYRK1A (0.49) DYRK1ANPC1RAB9ATP53
SCHEMBL498496 0.72 CYP1B1 (0.42) NPC1RAB9A
SCHEMBL7261654 0.71 CYP19A1 (0.41) NPC1RAB9APOLBAPPTP53
SCHEMBL499169 0.71 PDE4A (0.44) NPC1RAB9AL3MBTL1
SCHEMBL4266561 0.70 ME2 (0.34) NPC1RAB9AME2ME1ME3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431117-B2 Sickled erythrocytes with anti-tumor agents induce tumor vaso-occlusion and tumoricidal effects TERMAN DAVID S (US) 2013-04-30 — — US disclosed
US-20120195869-A1 Sickled Erythrocytes with Anti-tumor Agents Induce Tumor Vaso-occlusion and Tumoricidal Effects TERMAN DAVID S (US) 2012-08-02 — — US disclosed
Send feedback